IL130403A - Oil bodies and associated proteins as affinity matrices - Google Patents
Oil bodies and associated proteins as affinity matricesInfo
- Publication number
- IL130403A IL130403A IL13040397A IL13040397A IL130403A IL 130403 A IL130403 A IL 130403A IL 13040397 A IL13040397 A IL 13040397A IL 13040397 A IL13040397 A IL 13040397A IL 130403 A IL130403 A IL 130403A
- Authority
- IL
- Israel
- Prior art keywords
- oil body
- oil
- oil bodies
- associated proteins
- affinity matrices
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G11/00—Compounds of cadmium
- C01G11/003—Preparation involving a liquid-liquid extraction, an adsorption or an ion-exchange
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B1/00—Preparatory treatment of cellulose for making derivatives thereof, e.g. pre-treatment, pre-soaking, activation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Materials Engineering (AREA)
- Botany (AREA)
- Polymers & Plastics (AREA)
- Peptides Or Proteins (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
A method for the separation of a target molecule from a mixture is described. The method employs oil bodies and their associated proteins as affinity matrices for the selective, non-covalent binding of desired target molecules. The oil body proteins may be genetically fused to a ligand having specificity for the desired target molecule. Native oil body proteins can also be used in conjunction with an oil body protein specific ligand such as an antibody or an oil body binding protein. The method allows the separation and recovery of the desired target molecules due to the difference in densities between oil bodies and aqueous solutions.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/767,026 US5856452A (en) | 1996-12-16 | 1996-12-16 | Oil bodies and associated proteins as affinity matrices |
PCT/CA1997/000951 WO1998027115A1 (en) | 1996-12-16 | 1997-12-05 | Oil bodies and associated proteins as affinity matrices |
Publications (2)
Publication Number | Publication Date |
---|---|
IL130403A0 IL130403A0 (en) | 2000-06-01 |
IL130403A true IL130403A (en) | 2005-05-17 |
Family
ID=25078275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13040397A IL130403A (en) | 1996-12-16 | 1997-12-05 | Oil bodies and associated proteins as affinity matrices |
Country Status (19)
Country | Link |
---|---|
US (5) | US5856452A (en) |
EP (1) | EP1007554B1 (en) |
JP (2) | JP3833719B2 (en) |
KR (1) | KR100421935B1 (en) |
CN (1) | CN1325513C (en) |
AR (1) | AR010780A1 (en) |
AT (1) | ATE321777T1 (en) |
AU (1) | AU739339B2 (en) |
BR (1) | BR9713727B1 (en) |
CA (1) | CA2275489C (en) |
DE (1) | DE69735599T2 (en) |
DK (1) | DK1007554T3 (en) |
ES (1) | ES2259193T3 (en) |
HK (1) | HK1025977A1 (en) |
IL (1) | IL130403A (en) |
NZ (1) | NZ336558A (en) |
TW (1) | TW589322B (en) |
WO (1) | WO1998027115A1 (en) |
ZA (1) | ZA9711237B (en) |
Families Citing this family (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5856452A (en) * | 1996-12-16 | 1999-01-05 | Sembiosys Genetics Inc. | Oil bodies and associated proteins as affinity matrices |
US20050106157A1 (en) * | 1997-05-27 | 2005-05-19 | Deckers Harm M. | Immunogenic formulations comprising oil bodies |
AU772919C (en) * | 1997-05-27 | 2004-12-16 | Sembiosys Genetics Inc. | Uses of oil bodies |
US7585645B2 (en) | 1997-05-27 | 2009-09-08 | Sembiosys Genetics Inc. | Thioredoxin and thioredoxin reductase containing oil body based products |
US6372234B1 (en) * | 1997-05-27 | 2002-04-16 | Sembiosys Genetics Inc. | Products for topical applications comprising oil bodies |
US6761914B2 (en) | 1997-05-27 | 2004-07-13 | Sembiosys Genetics Inc. | Immunogenic formulations comprising oil bodies |
US6599513B2 (en) | 1997-05-27 | 2003-07-29 | Sembiosys Genetics Inc. | Products for topical applications comprising oil bodies |
CA2291274C (en) * | 1997-05-27 | 2006-05-16 | Sembiosys Genetics Inc. | Uses of oil bodies |
EP1131047A1 (en) * | 1998-11-25 | 2001-09-12 | SemBioSys Genetics, Inc. | Oil bodies as topical delivery vehicles for active agents |
DE60136928D1 (en) * | 2000-06-16 | 2009-01-22 | Sembiosys Genetics Inc | USE OF PLANT OIL BODY IN VACCINATE ADMINISTRATION SYSTEMS |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
TWI317736B (en) * | 2000-12-19 | 2009-12-01 | Sembiosys Genetics Inc | Methods for the production of redox proteins and heteromultimeric-protein-complexes, and related compositions related applications |
US7098383B2 (en) * | 2000-12-19 | 2006-08-29 | Sembiosys Genetics Inc. | Methods for the production of multimeric immunoglobulins, and related compositions |
US20030167524A1 (en) * | 2000-12-19 | 2003-09-04 | Rooijen Gijs Van | Methods for the production of multimeric protein complexes, and related compositions |
US20060179514A1 (en) * | 2001-07-05 | 2006-08-10 | Sembiosys Genetics, Inc. | Methods for the production of multimeric protein complexes, and related compositions |
EP2305311A3 (en) | 2001-10-10 | 2011-07-20 | BioGeneriX AG | Glycoconjugation of peptides |
ES2516041T3 (en) | 2001-10-10 | 2014-10-30 | Ratiopharm Gmbh | Remodeling and glycoconjugation of human growth hormone (hGH) |
US6806078B2 (en) * | 2002-08-27 | 2004-10-19 | William A. Newman | Substrate and method for anaerobic remediation |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US7704518B2 (en) * | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US20060018937A1 (en) * | 2002-10-25 | 2006-01-26 | Foamix Ltd. | Steroid kit and foamable composition and uses thereof |
US20080317679A1 (en) * | 2002-10-25 | 2008-12-25 | Foamix Ltd. | Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses |
US10117812B2 (en) * | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
CA2502986C (en) * | 2002-10-25 | 2011-08-23 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
US7820145B2 (en) * | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US20070292355A1 (en) * | 2002-10-25 | 2007-12-20 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US20070292359A1 (en) * | 2002-10-25 | 2007-12-20 | Foamix Ltd. | Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US20060193789A1 (en) * | 2002-10-25 | 2006-08-31 | Foamix Ltd. | Film forming foamable composition |
US8119109B2 (en) * | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US9265725B2 (en) * | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US20050205086A1 (en) * | 2002-10-25 | 2005-09-22 | Foamix Ltd. | Retinoid immunomodulating kit and composition and uses thereof |
US20050186142A1 (en) * | 2002-10-25 | 2005-08-25 | Foamix Ltd. | Kit and composition of imidazole with enhanced bioavailability |
US20050271596A1 (en) * | 2002-10-25 | 2005-12-08 | Foamix Ltd. | Vasoactive kit and composition and uses thereof |
US20080206161A1 (en) * | 2002-10-25 | 2008-08-28 | Dov Tamarkin | Quiescent foamable compositions, steroids, kits and uses thereof |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US8486376B2 (en) * | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
MXPA05010773A (en) | 2003-04-09 | 2005-12-12 | Neose Technologies Inc | Glycopegylation methods and proteins/peptides produced by the methods. |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
AR044803A1 (en) * | 2003-06-17 | 2005-10-05 | Sembiosys Genetics Inc | METHODS FOR INSULIN PRODUCTION |
WO2004113540A1 (en) * | 2003-06-18 | 2004-12-29 | The University Of York | Expression of heterologous protein |
US8486374B2 (en) * | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
JP2007503428A (en) * | 2003-08-25 | 2007-02-22 | フォーミックス エルティーディー. | Osmotic pharmaceutical foaming agent |
CA2539486A1 (en) * | 2003-10-02 | 2005-04-07 | Sembiosys Genetics Inc. | Methods for preparing oil bodies comprising active ingredients |
BRPI0612428A2 (en) * | 2005-05-09 | 2010-11-09 | Foamix Ltd | hygroscopic pharmaceutical composition, foamy pharmaceutical vehicle and foamy pharmaceutical composition |
US20080152596A1 (en) * | 2005-07-19 | 2008-06-26 | Foamix Ltd. | Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof |
US7256014B2 (en) * | 2005-07-27 | 2007-08-14 | E. I. Du Pont De Nemours And Company | Method to increase hydrophobic compound titer in a recombinant microorganism |
CA2626390C (en) * | 2005-10-19 | 2018-02-20 | Agriculture Victoria Services Pty Ltd | Polyoleosins |
CA2655764A1 (en) * | 2006-07-11 | 2008-01-17 | Basf Se | Protein targeting to lipid bodies |
BRPI0714754A2 (en) * | 2006-09-08 | 2013-05-14 | Foamix Ltd | topically colored or colored composition, method for changing the color of a typically colored or colorable composition and kit for topically applying |
EP2073794A2 (en) * | 2006-11-14 | 2009-07-01 | Foamix Ltd. | Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses |
US20080260655A1 (en) * | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
CA2674213A1 (en) * | 2007-01-26 | 2008-07-31 | Merck Serono S.A. | Purification of fc-taci fusion proteins using the oilbody technology |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US20090130029A1 (en) * | 2007-11-21 | 2009-05-21 | Foamix Ltd. | Glycerol ethers vehicle and pharmaceutical compositions thereof |
WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
WO2009090495A2 (en) * | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
WO2009089117A1 (en) * | 2008-01-04 | 2009-07-16 | Hormel Foods Corporation | Encapsulation of oxidatively unstable compounds |
US20110020519A1 (en) * | 2008-01-04 | 2011-01-27 | Aveka, Inc. | Encapsulation of oxidatively unstable compounds |
AU2009205314A1 (en) * | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
US8592555B2 (en) | 2008-08-11 | 2013-11-26 | Emd Millipore Corporation | Immunoglobulin-binding proteins with improved specificity |
SG162687A1 (en) * | 2008-12-24 | 2010-07-29 | Millipore Corp | Caustic stable chromatography ligands |
CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
CA2776366C (en) | 2009-10-02 | 2017-07-18 | Foamix Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
TWI377954B (en) * | 2009-11-25 | 2012-12-01 | Univ China Medical | Oil body carriers, uses in target therapy and/or detection of the same, and fusion proteins comprised therein |
CN102100914A (en) * | 2010-12-21 | 2011-06-22 | 陈顺基 | Artificial oil body carrier for targeted therapy of mastocarcinoma as well as preparation method and application thereof |
SG186552A1 (en) | 2011-06-08 | 2013-01-30 | Emd Millipore Corp | Chromatography matrices including novel staphylococcus aureus protein a based ligands |
FI20115704L (en) | 2011-07-01 | 2013-01-02 | Teknologian Tutkimuskeskus Vtt Oy | Enhancement of foreign protein production |
CA2841473C (en) | 2011-07-12 | 2020-08-11 | Maraxi, Inc. | Methods and compositions for consumables |
US20140220217A1 (en) | 2011-07-12 | 2014-08-07 | Maraxi, Inc. | Method and compositions for consumables |
EP2731451B1 (en) | 2011-07-12 | 2018-09-05 | Impossible Foods Inc. | Methods and compositions for consumables |
US10039306B2 (en) | 2012-03-16 | 2018-08-07 | Impossible Foods Inc. | Methods and compositions for consumables |
AU2014205122B2 (en) | 2013-01-11 | 2017-11-02 | Impossible Foods Inc. | Non-dairy cheese replica comprising a coacervate |
RU2019128577A (en) | 2013-01-11 | 2019-10-14 | Импоссибл Фудз Инк. | METHODS AND COMPOSITIONS FOR IMPACT ON THE PROFILE OF TASTE AND FRAGRANCE SUITABLE FOR CONSUMPTION OF SUBSTANCES |
EP3628173A1 (en) | 2014-03-31 | 2020-04-01 | Impossible Foods Inc. | Ground meat replicas |
PL3362151T3 (en) | 2015-10-15 | 2020-11-30 | Cargill, Incorporated | Composition containing oleosomes of different size distribution |
MX2017011630A (en) | 2016-09-08 | 2018-09-25 | Foamix Pharmaceuticals Ltd | Compositions and methods for treating rosacea and acne. |
US20200131553A1 (en) * | 2016-10-03 | 2020-04-30 | Alcantara Research Group Inc. | A chloroplast or accumulated lipid particle enriched with an oil-body protein fusion polypeptide and method for producing the same in algae |
DE102017219800B4 (en) * | 2017-11-08 | 2021-09-23 | Helmholtz-Zentrum Dresden - Rossendorf E. V. | Peptide carrier materials as biofunctionalized collectors |
US20220151257A1 (en) | 2019-03-19 | 2022-05-19 | Conopco, Inc., D/B/A Unilever | Frozen confection |
CN110776571B (en) * | 2019-11-04 | 2021-08-10 | 福建省中医药研究院(福建省青草药开发服务中心) | Metallothionein fusion protein construction, rapid preparation of immobilized carrier and application of metallothionein fusion protein construction and immobilized carrier in heavy metal ion removal |
US20240122199A1 (en) * | 2021-02-26 | 2024-04-18 | Societe Des Produits Nestle S.A. | Low ph co-extraction method of preparing a stable oil body solution |
CN113176362B (en) * | 2021-06-30 | 2021-11-19 | 中国农业科学院蜜蜂研究所 | Method for evaluating allergenicity of natural bee pollen and fermented bee pollen |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3819079A1 (en) * | 1988-06-04 | 1989-12-07 | Hoechst Ag | HIRUDINE DERIVATIVES WITH DELAYED EFFECT |
US5650554A (en) * | 1991-02-22 | 1997-07-22 | Sembiosys Genetics Inc. | Oil-body proteins as carriers of high-value peptides in plants |
US5474925A (en) * | 1991-12-19 | 1995-12-12 | Agracetus, Inc. | Immobilized proteins in cotton fiber |
ES2227511T3 (en) * | 1992-04-15 | 2005-04-01 | Sembiosys Genetics Inc. | PROTEINS WITH OIL BODY AS VECTORS OF GREAT VALUE PEPTIDES IN VEGETABLES. |
US5856452A (en) * | 1996-12-16 | 1999-01-05 | Sembiosys Genetics Inc. | Oil bodies and associated proteins as affinity matrices |
-
1996
- 1996-12-16 US US08/767,026 patent/US5856452A/en not_active Expired - Lifetime
-
1997
- 1997-12-05 KR KR10-1999-7005364A patent/KR100421935B1/en not_active IP Right Cessation
- 1997-12-05 IL IL13040397A patent/IL130403A/en not_active IP Right Cessation
- 1997-12-05 AT AT97946991T patent/ATE321777T1/en active
- 1997-12-05 JP JP52713498A patent/JP3833719B2/en not_active Expired - Fee Related
- 1997-12-05 US US09/319,275 patent/US6509453B1/en not_active Expired - Fee Related
- 1997-12-05 NZ NZ336558A patent/NZ336558A/en not_active IP Right Cessation
- 1997-12-05 CN CNB971815070A patent/CN1325513C/en not_active Expired - Fee Related
- 1997-12-05 WO PCT/CA1997/000951 patent/WO1998027115A1/en active IP Right Grant
- 1997-12-05 CA CA002275489A patent/CA2275489C/en not_active Expired - Fee Related
- 1997-12-05 ES ES97946991T patent/ES2259193T3/en not_active Expired - Lifetime
- 1997-12-05 DK DK97946991T patent/DK1007554T3/en active
- 1997-12-05 AU AU52204/98A patent/AU739339B2/en not_active Ceased
- 1997-12-05 EP EP97946991A patent/EP1007554B1/en not_active Expired - Lifetime
- 1997-12-05 BR BRPI9713727-8A patent/BR9713727B1/en not_active IP Right Cessation
- 1997-12-05 DE DE69735599T patent/DE69735599T2/en not_active Expired - Lifetime
- 1997-12-12 TW TW086118737A patent/TW589322B/en not_active IP Right Cessation
- 1997-12-15 ZA ZA9711237A patent/ZA9711237B/en unknown
- 1997-12-16 AR ARP970105903A patent/AR010780A1/en active IP Right Grant
-
2000
- 2000-08-23 HK HK00105294A patent/HK1025977A1/en not_active IP Right Cessation
- 2000-11-07 US US09/707,167 patent/US6924363B1/en not_active Expired - Fee Related
-
2002
- 2002-10-01 US US10/260,960 patent/US7332587B2/en not_active Expired - Fee Related
- 2002-10-01 US US10/260,562 patent/US20030096320A1/en not_active Abandoned
-
2006
- 2006-05-31 JP JP2006152338A patent/JP2006306881A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR100421935B1 (en) | 2004-03-10 |
US20030096320A1 (en) | 2003-05-22 |
US6924363B1 (en) | 2005-08-02 |
JP3833719B2 (en) | 2006-10-18 |
EP1007554A1 (en) | 2000-06-14 |
DK1007554T3 (en) | 2006-05-01 |
CA2275489A1 (en) | 1998-06-25 |
ATE321777T1 (en) | 2006-04-15 |
AU739339B2 (en) | 2001-10-11 |
JP2001506241A (en) | 2001-05-15 |
CN1245503A (en) | 2000-02-23 |
NZ336558A (en) | 2001-08-31 |
HK1025977A1 (en) | 2000-12-01 |
US20030059910A1 (en) | 2003-03-27 |
US6509453B1 (en) | 2003-01-21 |
AR010780A1 (en) | 2000-07-12 |
KR20000069499A (en) | 2000-11-25 |
DE69735599T2 (en) | 2006-08-31 |
US5856452A (en) | 1999-01-05 |
US7332587B2 (en) | 2008-02-19 |
IL130403A0 (en) | 2000-06-01 |
BR9713727B1 (en) | 2009-01-13 |
CA2275489C (en) | 2007-03-27 |
AU5220498A (en) | 1998-07-15 |
EP1007554B1 (en) | 2006-03-29 |
JP2006306881A (en) | 2006-11-09 |
ZA9711237B (en) | 1998-07-06 |
DE69735599D1 (en) | 2006-05-18 |
BR9713727A (en) | 2000-01-25 |
CN1325513C (en) | 2007-07-11 |
ES2259193T3 (en) | 2006-09-16 |
TW589322B (en) | 2004-06-01 |
WO1998027115A1 (en) | 1998-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1025977A1 (en) | Oil bodies and associated proteins as affinity matrices | |
WO1991012023A3 (en) | Hybrid reagents capable of selectively releasing molecules into cells | |
DK0458841T3 (en) | Process for use and preparation of peptides | |
CA2155185A1 (en) | Totally synthetic affinity reagents | |
CA2265935A1 (en) | Heat shock protein complexes | |
SG65593A1 (en) | Totally synthetic affinity reagents | |
EP0215625A3 (en) | Protein recovery | |
AU586666B2 (en) | Proteins immobilised on polyamides or cellulose hydrate and the use thereof for the preparation of biocatalysts, test strips or chromatography materials | |
Olson et al. | Localization of phosphoprotein C23 in nucleoli by immunological methods | |
HK1040093A1 (en) | Method of enhancing the biological activity of ligands. | |
CA2173102A1 (en) | Dna sequence coding for a bmp receptor | |
EP0239311A3 (en) | Mutual separation of proteins | |
SE9803224D0 (en) | Method of separation of macromolecules | |
WO1994026891A3 (en) | Purified mammalian flt3 ligands and agonists and antagonists thereof | |
WO2000018909A3 (en) | NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM) | |
Lane et al. | Multiple forms of α2u, a sex-dependent urinary protein of the adult male rat | |
AU2256197A (en) | High affinity nucleic acid ligands of complement system proteins | |
CA2180957A1 (en) | Cloning and recombinant production of crf receptor(s) | |
DE3583830D1 (en) | NORTRIPTYLINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR CONJUGATES WITH ANTIGENIC PROTEINS AND ENZYMES, ANTIBODIES THEREOF AND RELATED METHODS FOR DETERMINATION. | |
WO1999029724A3 (en) | Dna encoding pasteurella multocida outer membrane protein | |
Hoag et al. | Optimal conditions for isolating human placental alkaline phosphatase by immunosorption | |
KR890009417A (en) | Method for producing monoclonal antibody and method of using the same | |
EA199900663A1 (en) | NEW PROTEINS CONNECTING WITH RECEPTOR 1 INTERFERON, ENCODING THEIR DNA AND METHODS OF MODULATION OF CELLULAR RESPONSE TO INTERFERON | |
WO2001042296A3 (en) | Clasp-5 transmembrane protein | |
Borek | Immobilized enzymes, antigens, antibodies, and peptides—Preparation characterization: edited by Howard Weetall. Marcel Dekker, New York, 1975 (661 pp., illus.) $38.50 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |